- £29.04m
- £15.38m
- £2.19m
RCS - Angle PLC - Parsortix poster presented at ISLB meeting
AnnouncementREG - Angle PLC - Issue of Equity
AnnouncementREG - Angle PLC - Streamlining of operations to increase cash runway
AnnouncementREG - Angle PLC - TR-1: Notification of major holdings
AnnouncementRCS - Angle PLC - First regional distribution agreement
AnnouncementREG - AIM - AIM Notice - 05/10/2022
AnnouncementREG - Angle PLC - Issue of Equity
AnnouncementREG - Angle PLC Aegon N.V. - Holding(s) in Company
AnnouncementREG - Angle PLC - Positive headline results from ovarian study
AnnouncementREG - Angle PLC - Interim Results
AnnouncementRCS - Angle PLC - Study using Parsortix in head and neck cancer
AnnouncementRCS - Angle PLC - New poster presented at ASCP Meeting
AnnouncementRCS - Angle PLC - Novel assay predicts malignancy in pelvic mass
AnnouncementREG - Angle PLC - Notice of Interim Results and Webcast
AnnouncementRCS - Angle PLC - Novel insight into metastasis in NSCLC patients
AnnouncementREG - Angle PLC - Holding(s) in Company
AnnouncementRCS - Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
AnnouncementREG - Angle PLC - Director/PDMR Shareholding
AnnouncementREG - Angle PLC - Results of Capital Raise
Announcement